Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Boswellic acids reduce TH17 differentiation via blockade of IL-1β-Mediated IRAK1 signaling.
The current role of mitoxantrone in the treatment of multiple sclerosis.
Functional cerebral changes in multiple sclerosis patients during an autobiographical memory test.
Serum analysis by 1H Nuclear Magnetic Resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis.
Brain stem infarction associated with familial Mediterranean fever and central nervous system vasculitis.
Fingolimod-induced atrioventricular conduction defects in a young lady with multiple sclerosis - insights into possible drug mechanism.
Motor cortex rTMS improves dexterity in relapsing-remitting and secondary progressive multiple sclerosis.
[MRI and CSF features in neuromyelitis optica].
Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection.
[Magnetic resonance imaging of the brain in the monitoring of immune therapy of multiple sclerosis].
Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury.
Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters.
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.
High-Throughput Screening Platform for the Discovery of New Immunomodulator Molecules from Natural Product Extract Libraries.
Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study.
Age-dependent differences in microglial responses to systemic inflammation are evident as early as middle age.
Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells.
Clinical Characteristics and Urodynamic Analysis of Urinary Dysfunction in Multiple Sclerosis.
Assessment of a program to encourage the multidisciplinary management of urinary disorders in multiple sclerosis.
Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy.
Impaired functional integration in multiple sclerosis: a graph theory study.
Interdisciplinary exchange of ideas: progestagens for autoimmunity, biologics for pregnancy complications.
Spinal anesthesia for cesarean delivery in a woman with neuromyelitis optica.
Pages
« first
‹ previous
…
588
589
590
591
592
593
594
595
596
…
next ›
last »